AQR Arbitrage’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,000
Closed -$302K 1129
2021
Q1
$302K Sell
3,000
-2,000
-40% -$205K 0.01% 702
2020
Q4
$550K Hold
5,000
0.02% 612
2020
Q3
$525K Sell
5,000
-10,280
-67% -$1.06M 0.02% 401
2020
Q2
$1.56M Sell
15,280
-99,600
-87% -$9.89M 0.07% 226
2020
Q1
$11.3M Sell
114,880
-25,000
-18% -$2.47M 0.38% 73
2019
Q4
$14M Sell
139,880
-60,120
-30% -$5.96M 0.24% 100
2019
Q3
$19.9M Buy
+200,000
New +$19.6M 0.29% 75

Other funds holding CELU

AQR Arbitrage's CELU Position: Q2 2021 in Review

AQR Arbitrage sold out of Celularity (CELU) in Q2 2021, closing a stake of 3,000 shares — an estimated $302K sold.

AQR Arbitrage first reported a position in CELU in Q3 2019 and held it in 7 quarters. The position peaked at $19.9M in Q3 2019. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • AQR Arbitrage reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • AQR Arbitrage sold 3,000 Celularity shares in Q2 2021, an estimated $302K.
  • AQR Arbitrage first reported a position in Celularity in Q3 2019 and held it in 7 quarters.
  • AQR Arbitrage's Celularity position peaked at $19.9M in Q3 2019.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on AQR Arbitrage's 13F filing for Q2 2021, filed 16 Aug 2021.